EMBO Molecular Medicine (Mar 2014)

Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury

  • Sabyasachi Bhattacharya,
  • Kanstantsin V Katlinski,
  • Maximilian Reichert,
  • Shigetsugu Takano,
  • Angela Brice,
  • Bin Zhao,
  • Qiujing Yu,
  • Hui Zheng,
  • Christopher J Carbone,
  • Yuliya V Katlinskaya,
  • N Adrian Leu,
  • Kelly A McCorkell,
  • Satish Srinivasan,
  • Melanie Girondo,
  • Hallgeir Rui,
  • Michael J May,
  • Narayan G Avadhani,
  • Anil K Rustgi,
  • Serge Y Fuchs

DOI
https://doi.org/10.1002/emmm.201303236
Journal volume & issue
Vol. 6, no. 3
pp. 384 – 397

Abstract

Read online

Abstract Type 1 interferons (IFN) protect the host against viruses by engaging a cognate receptor (consisting of IFNAR1/IFNAR2 chains) and inducing downstream signaling and gene expression. However, inflammatory stimuli can trigger IFNAR1 ubiquitination and downregulation thereby attenuating IFN effects in vitro. The significance of this paradoxical regulation is unknown. Presented here results demonstrate that inability to stimulate IFNAR1 ubiquitination in the Ifnar1SA knock‐in mice renders them highly susceptible to numerous inflammatory syndromes including acute and chronic pancreatitis, and autoimmune and toxic hepatitis. Ifnar1SA mice (or their bone marrow‐receiving wild type animals) display persistent immune infiltration of inflamed tissues, extensive damage and gravely inadequate tissue regeneration. Pharmacologic stimulation of IFNAR1 ubiquitination is protective against from toxic hepatitis and fulminant generalized inflammation in wild type but not Ifnar1SA mice. These results suggest that endogenous mechanisms that trigger IFNAR1 ubiquitination for limiting the inflammation‐induced tissue damage can be purposely mimicked for therapeutic benefits.

Keywords